Innovating Transplantation,
Accelerating Research

Technology

The Apersys technology, backed by preclinical and first-in-human data, shows promise in preserving and restoring livers once deemed unfit for transplant.

About Us

Our team combines world leading 

science in liver transplantation with 

in-depth entrepreneurial expertise in medical devices.

 

Innovation

Discover the latest news, from the FDA Breakthrough Devices Designation to the recent publications in liver defatting. 



Supported by

Apersys AG

Apersys AG

Affolternstrasse 42 #301

8050 Zürich

Switzerland

© Apersys 2025
All rights reserved